Regencell Bioscience Holdings Limited (RGC) Operating income 2019–2025
Regencell Bioscience Holdings Limited (RGC) annual operating income history from SEC filings — each fiscal year as reported.
-$3.8MFY2025 · since FY2019: -$390,990 → -$3.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$3.8M | +20.4% |
| FY2024 | -$4.7M | +24.5% |
| FY2023 | -$6.3M | +17.6% |
| FY2022 | -$7.6M | -451.5% |
| FY2021 | -$1.4M | -70.0% |
| FY2020 | -$812,371 | -107.8% |
| FY2019 | -$390,990 | — |
Source: SEC XBRL filings · For reference only · Not investment advice